Friday, June 8

EDUCATION SESSION

08.00 - 09.30 hours, Room: Mozart I
16.00 - 17.30 hours, Room: Mozart I

ACUTE MYELOID LEUKEMIA

Chair: J. Holowiecki (Silesian Medical University, Katowice, Poland)

• TARGETING CRITICAL PATHWAYS IN LEUKEMIC STEM CELLS
  B. Huntly (University of Cambridge, Cambridge, United Kingdom)
• CLINICAL USE OF MOLECULAR MARKERS IN ADULT ACUTE MYELOID LEUKEMIA
  C. Bloomfield (Ohio State University, Columbus, USA)
• MANAGEMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA
  H. Dombret (Hopital Saint Louis, Paris, France)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Mozart II
14.15 - 15.45 hours, Room: Mozart II

CHRONIC LYMPHOCYTIC LEUKEMIA

Chair: E. Montserrat (Hospital Clinic, Barcelona, Spain)

• GENETICS IN CLL: IMPACT FOR PROGNOSIS AND TREATMENT DECISIONS
  U. Jäger (Medical University of Vienna, Vienna, Austria)
• STATE-OF-THE-ART TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
  M. Hallek (University of Cologne, Cologne, Germany)
• NEW DRUGS FOR CLL
  J. Gribben (Barts and The London School of Medicine, London, United Kingdom)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Mozart III
14.15 - 15.45 hours, Room: Strauss I

MYELOPROLIFERATIVE DISORDERS

Chair: R. Skoda (Basel University Hospital, Basel, Switzerland)

• MOLECULAR PATHOGENESIS OF THE MYELOPROLIFERATIVE DISEASES
  W. Vainchencker (INSERM, Villejuif, France)
• DIAGNOSIS AND CLASSIFICATION OF MPDS IN THE JAK2 ERA
  C. Harrison (Guy's & St. Thomas' Hospital, London, United Kingdom)
• CONVENTIONAL AND NEW TREATMENT MODALITIES IN MYELOFIBROSIS
  F. Cervantes (Hospital Clinic, Barcelona, Spain)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Strauss I
16.00 - 17.30 hours, Room: Strauss I

HODGKIN’S LYMPHOMA

Chair: A. Sureda (Hospital de la Santa Creu i Sant Pau, Barcelona, Spain)

• THE ROLE OF PET IN STAGING AND RESPONSE ASSESSMENT
  L. Specht (Rigshospitalet, Copenhagen, Denmark)
• TAILORING THE TREATMENT FOR EARLY-STAGE HODGKIN'S LYMPHOMA
  M. André (Centre Hospitalier Notre Dame & Reine Fabiola, Charleroi, Belgium)
• TREATMENT OF RELAPSING / REFRACTORY PATIENTS WITH HODGKIN’S LYMPHOMA
  P. Brice (Hopital Saint Louis, Paris, France)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Strauss II
14.15 - 15.45 hours, Room: Léhar I+II

CHRONIC MYELOID LEUKEMIA

Chair: M. Deininger (Oregon Health & Science University, Portland, OR, USA)

• CLINICAL IMPLICATIONS OF ABL MUTATIONAL SCREENING
  J. Duyster (Technical University Munich, Munich, Germany)
• DECISION MAKING AT DIAGNOSIS IN CHRONIC MYELOID LEUKEMIA
  M. Baccarani (University of Bologna, Bologna, Italy)
• MANAGEMENT OF PATIENTS WITH IMATINIB RESISTANCE
  E. Olavarria (Imperial College London, London, United Kingdom)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Strauss III
14.15 - 15.45 hours, Room: Strauss III

IRON METABOLISM AND DISEASE

Chair: M. Worwood (Cardiff University, School of Medicine, Cardiff, United Kingdom)

• MECHANISMS OF IRON REGULATION AND OF IRON DEFICIENCY
  C. Hershko (Shaare Zedek Medical Center, Jerusalem, Israel)
• PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT OF THE ANEMIA OF CHRONIC DISEASE
  G. Weiss (Universitätsklinik für Innere Medizin, Innsbruck, Austria)
• SCREENING HEMOCHROMATOSIS AND IRON OVERLOAD
  C. Camaschella (University Vita-Salute San Raffaele, Milan, Italy)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Léhar I+II
16.00 - 17.30 hours, Room: Strauss II

TRANSFUSION - DIAGNOSIS AND MANAGEMENT OF ALLOIMMUNE THROMBOCYTOPENIA

Chair: W. Ouwehand (University of Cambridge, Cambridge, United Kingdom)

• HUMAN PLATELET ALLOANTIGENS: HETEROGENEITY OF PLATELET ALLOANTIBODIES
  S. Santoso (Justus Liebig University, Giessen, Germany)
• LABORATORY DIAGNOSIS OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
  L. Porcelijn (Sanquin Research, Amsterdam, The Netherlands)
• TREATMENT AND PREVENTION OF ALLOIMMUNE THROMBOCYTOPENIAS
  A. Husebekk (University Hospital of Northern Norway, Tromsö, Norway)

EDUCATION SESSION

08.00 - 09.30 hours, Room: Léhar III+IV
16.00 - 17.30 hours, Room: Léhar III+IV

HEMOSTASIS

Chair: E. Santagostino (Ospedale Maggiore di Milano, Milan, Italy)

• EPIDEMIOLOGY OF COAGULATION DISORDERS
  F. Peyvandi (University of Milan, Milan, Italy)
• RECENT ADVANCES IN HEMOPHILIA MANAGEMENT
  C. Negrier (Edouard Herriot University Hospital, Lyon, France)
• GENE THERAPY FOR HEMOPHILIA
  T. Vandendriessche (Catholic University, Leuven, Belgium)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Mozart I
16.00 - 17.30 hours, Room: Mozart II

MYELOMA

Chair: H. Ludwig (Wilhelminenspital, Vienna, Austria)

• ADVANCES IN MYELOMA BIOLOGY: BASIS FOR NEW THERAPY
  N. Munshi (Dana Farber Cancer Institute, Boston, USA)
• MULTIPLE MYELOMA: DIAGNOSIS, STAGING AND CRITERIA OF RESPONSE
  J. Bladé (Hospital Clinic of Barcelona, Barcelona, Spain)
• NOVEL TREATMENT APPROACHES IN MULTIPLE MYELOMA
  A. Palumbo (Az. Ospedaliera Molinette, Turin, Italy)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Mozart II
14.15 - 15.45 hours, Room: Mozart I

WHAT’S NEW IN T-CELL NON-HODGKIN’S LYMPHOMAS?

Chair: M. Trneny (Charles University General Hospital, Prague, Czech Republic)

• PATHOLOGY AND GENETICS OF T-CELL LYMPHOMAS
  A. Chott (University of Vienna, Vienna, Austria)
• CURRENT TREATMENT OF T-CELL LYMPHOMAS: ARE WE MAKING ANY PROGRESS?
  A. Delmer (University Hospital, Reims, France)
• NOVEL DRUGS FOR THE TREATMENT OF T-CELL LYMPHOMA
  O. O'Connor (Memorial Sloan-Kettering Cancer Center, New York, USA)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Mozart III
14.15 - 15.45 hours, Room: Mozart III

MYELODYSPLASTIC SYNDROMES

Chair: D. Bowen (The Leeds Teaching Hospitals, Leeds, United Kingdom)

• MOLECULAR PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES
  C. Niemeyer (University of Freiburg, Freiburg, Germany)
• EPIGENETIC THERAPY IN MDS
  P. Fenaux (Hopital Avicenne, Paris, France)
• NEW DEVELOPMENTS IN CURATIVE APPROACHES IN MYELODYSPLASIA
  T. De Witte (Academic Hospital Nijmegen, Nijmegen, The Netherlands)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Strauss I
16.00 - 17.30 hours, Room: Mozart III

ACUTE LYMPHOBLASTIC LEUKEMIA

Chair: J. Ribera (Germans Trias i Pujol Hospital, Badalona, Spain)

• GENETICS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
  C. Harrison (University of Southampton, Southampton, United Kingdom)
• TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)
  O. Ottman (J.W. Goethe University, Frankfurt, Germany)
• DETECTION OF MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: METHODOLOGICAL ADVANCES AND CLINICAL SIGNIFICANCE
  M. Brüggemann (Universitätsklinikums Schleswig-Holstein, Kiel, Germany)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Strauss II
16.00 - 17.30 hours, Room: Léhar I+II

CELLULAR IMMUNOTHERAPY AND VACCINATION

Chair: M. Theobald (University Medical Center Utrecht, Utrecht, The Netherlands)

• THE MOLECULAR AND CELLULAR BASIS FOR IMMUNOTHERAPEUTIC INTERVENTION IN MALIGNANT DISEASE: DYNAMIC IMAGING OF THE IMMUNE SYSTEM
  C. Lotz (University Medical Center Utrecht, Utrecht, The Netherlands)
• IMMUNOTHERAPY OF LEUKEMIA WITH TCR GENE MODIFIED T-CELLS
  H. Stauss (University College London, London, United Kingdom)
• PERSPECTIVES AND LIMITATIONS OF CLINICAL ANTI-MALIGNANCY VACCINATION STRATEGIES
  P. Romero (Ludwig Institute for Cancer Research, Lausanne, Switzerland)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Strauss III
16.00 - 17.30 hours, Room: Strauss III

SICKLE CELL DISEASE

Chair: I. Roberts (Imperial College, London, United Kingdom)

• HEMOLYSIS-ASSOCIATED PULMONARY HYPERTENSION IN SICKLE CELL DISEASE AND THALASSEMIA
  G. Kato (National Heart, Lung, and Blood Institute, Bethesda, USA)
• THE CONTRIBUTION OF ASTHMA TO SICKLE CELL DISEASE RELATED MORBIDITY AND MORTALITY
  M. DeBaun (Washington School of Medicine, St. Louis, USA)
• HYDROXYUREA: BENEFITS AND RISKS IN PATIENTS AFFECTED WITH SICKLE CELL ANEMIA
  M. de Montalembert (Hopital Necker, Paris, France)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Léhar I+II
14.15 - 15.45 hours, Room: Strauss II

NEW AND EVOLVING TECHNIQUES IN DIAGNOSTIC HEMATOLOGY

Chair: L. Degos (Haute Autorité de Santé, Paris, France)

• GENOME-WIDE APPROACHES TO IDENTIFY NEW SUBTYPES OF ACUTE MYELOID LEUKEMIA (AML)
  P. Valk (Erasmus MC, Rotterdam, The Netherlands)
• WHICH NEW TESTS SHOULD BE OFFERED BY CLINICAL HEMOSTASIS LABORATORIES?
  M. Greaves (University of Aberdeen, Aberdeen, United Kingdom)
• THE ROLE OF MOLECULAR ANALYSIS IN THE INVESTIGATION OF INHERITED ANEMIAS
  A. Iolascon (European School of Molecular Medicine, Naples, Italy)

EDUCATION SESSION

09.45 - 11.15 hours, Room: Léhar III+IV
14.15 - 15.45 hours, Room: Léhar III+IV

THROMBOSIS

Chair: I. Pabinger (Medical University of Vienna, Vienna, Austria)

• VKORC1: PHARMACOGENETICS AND ORAL ANTICOAGULATION
  J. Oldenburg (University of Würzburg, Würzburg, Germany)
• DO ARTERIAL AND VENOUS THROMBOSIS SHARE COMMON RISK FACTORS?
  G. Lowe (Glasgow Royal Infirmary, Glasgow, United Kingdom)
• VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS: STRATIFICATION AND PREVENTION
  P. Prandoni (University of Padua, Padua, Italy)